Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents
Clinical trial NCT05346731 · UNKNOWN
Trial details
- NCT number
- NCT05346731
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-01
- Primary completion
- 2024-03-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.